4.4 Article

Hepatology Consultants Often Disagree on Etiology of Abnormal Liver Biochemistries in COVID-19 but Agree on Management

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Liver Biochemistries in Hospitalized Patients With COVID-19

Patricia P. Bloom et al.

Summary: In COVID-19 patients, abnormalities in liver biochemistries, particularly AST and ALT, are common on admission and throughout the course of illness. Aminotransferases are frequently elevated, while alkaline phosphatase and total bilirubin elevations are rare. AST-dominant aminotransferase elevation seems to correlate with disease severity and reflects true hepatic injury.

HEPATOLOGY (2021)

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

Article Medicine, General & Internal

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

Safiya Richardson et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Gastroenterology & Hepatology

COVID-19: Abnormal liver function tests

Qingxian Cai et al.

JOURNAL OF HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Clinical Features of COVID-19-Related Liver Functional Abnormality

Zhenyu Fan et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)

Review Gastroenterology & Hepatology

COVID-19 and the liver

Dinesh Jothimani et al.

JOURNAL OF HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Abnormal liver function tests predict transfer to intensive care unit and death in COVID-19

Salvatore Piano et al.

LIVER INTERNATIONAL (2020)

Review Gastroenterology & Hepatology

ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries

Paul Y. Kwo et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)